Current portfolio
Agomab Therapeutics
Agomab Therapeutics is a biotechnology company developing therapies that aim to preserve and restore organ function in fibrotic diseases
- SectorHealthcare
- CountryBelgium
- FundLSP 7
- Entry2023
- Web
![Agomab Therapeutics](https://cdn.sanity.io/images/30p7so6x/eqt-web-prod/8e554908099e6bd97aef01c987a1c747cdd03e7a-740x252.png?h=50&fit=scale)
Agomab Therapeutics is a biotechnology company developing therapies that aim to preserve and restore organ function in fibrotic diseases